Citius Pharmaceuticals Inc (FRA:47N)
€ 0.3454 0.0234 (7.27%) Market Cap: 75.77 Mil Enterprise Value: 59.35 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 29/100

Citius Pharmaceuticals Inc at ThinkEquity Conference Transcript

Oct 26, 2022 / 05:00PM GMT
Release Date Price: €1.04 (-0.42%)
Unidentified Participant

(technical difficulty) Citius Pharmaceuticals, Dr. Leonard Mazur.

Leonard Mazur
Citius Pharmaceuticals, Inc. - Co-founder, CEO and Chairman of the Board of Directors

I'm not a doctor. Thank you. He gave me a degree I didn't have, so that's okay. Thank you. First of all, I want to thank all of you for being here today for taking the time out to come here and listen to our presentation. And hopefully by the time this is concluded, you'll know something that you didn't know before.

So with that, since I'm going to be making forward-looking statements, what we strongly advise everybody to do is you should be as informed as possible. So we advise you to consult our website, citiuspharma.com or the SEC website sec.gov, and put in our symbol CTXR. With that, you'll get all the information you want, and it's on our website. Same information that's on the SEC website is also located on our website as well.

So with that, let me just give you a quick overview here in terms of the company. We'd like to pride ourselves on the fact that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot